Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W H Stuart

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Otolaryngologic Clinics of North America|May 1, 1982
Geriatric neurology for the otolaryngologistW H Stuart
Journal of the Medical Association of Georgia|August 1, 1970
L-dopa and parkinsonismW H Stuart
Journal of the Medical Association of Georgia|June 1, 1972
Indications for cerebral angiography in cerebrovascular disease. A neurologist's approachW H Stuart
Clinical Therapeutics|January 7, 1998
Rationale for early treatment with interferon beta-1a in relapsing-remitting multiple sclerosisF E Munschauer, W H Stuart
Neurology|January 1, 1989
Guidelines on the vegetative state: commentary on the American Academy of Neurology statementT L Munsat, W H Stuart, R E Cranford
Neurology|April 1, 1970
Hereditary cerebello-olivary degeneration of late onsetP M Hoffman, W H Stuart, K M Earle, et al.
European Journal of Immunology|August 15, 2000
A novel population of B7-1+ T cells producing intracellular IL-4 is decreased in patients with multiple sclerosisB Kipp, A Bar-Or, R Gausling, et al.
Neurology|January 24, 2002
Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines [RETIRED]D S Goodin, E M Frohman, G P Garmany, et al.
The Journal of Infectious Diseases|October 1, 1978
An outbreak in 1965 of severe respiratory illness caused by the Legionnaires' disease bacteriumS B Thacker, J V Bennett, T F Tsai, et al.
Neurology|September 10, 2003
The utility of MRI in suspected MS [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyE M Frohman, D S Goodin, P A Calabresi, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Otolaryngologic Clinics of North America|May 1, 1982
Geriatric neurology for the otolaryngologistW H Stuart
Journal of the Medical Association of Georgia|August 1, 1970
L-dopa and parkinsonismW H Stuart
Journal of the Medical Association of Georgia|June 1, 1972
Indications for cerebral angiography in cerebrovascular disease. A neurologist's approachW H Stuart
Clinical Therapeutics|January 7, 1998
Rationale for early treatment with interferon beta-1a in relapsing-remitting multiple sclerosisF E Munschauer, W H Stuart
Neurology|January 1, 1989
Guidelines on the vegetative state: commentary on the American Academy of Neurology statementT L Munsat, W H Stuart, R E Cranford
Neurology|April 1, 1970
Hereditary cerebello-olivary degeneration of late onsetP M Hoffman, W H Stuart, K M Earle, et al.
European Journal of Immunology|August 15, 2000
A novel population of B7-1+ T cells producing intracellular IL-4 is decreased in patients with multiple sclerosisB Kipp, A Bar-Or, R Gausling, et al.
Neurology|January 24, 2002
Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines [RETIRED]D S Goodin, E M Frohman, G P Garmany, et al.
The Journal of Infectious Diseases|October 1, 1978
An outbreak in 1965 of severe respiratory illness caused by the Legionnaires' disease bacteriumS B Thacker, J V Bennett, T F Tsai, et al.
Neurology|September 10, 2003
The utility of MRI in suspected MS [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyE M Frohman, D S Goodin, P A Calabresi, et al.
Pageof 2